Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Study of APTA-2217 in Adult Patients With Bronchial Asthma
NCT00246922Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2004
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roflumilast in asthma, sponsored by AstraZeneca. Started Dec 2004; status: completed.
02
Drugs
roflumilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00246922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00246922.